Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exxon Mobil Corporation (XOM) Stock Is Going Nowhere

Page 1 of 2

No two ways about it: Exxon Mobil Corporation (NYSE:XOM) has disappointed investors mightily this past year.

The mere 7% rise in price in the world’s premier “oil stock” works out to less than half the gains seen elsewhere on the S&P 500. It’s risen less than half as high as archrival Chevron Corporation (NYSE:CVX). Indeed, Exxon Mobil Corporation (NYSE:XOM) stock has even underperformed BP plc (ADR) (NYSE:BP) — and last I heard, Exxon hasn’t blown up any gulf oil platforms lately.

But why is Exxon underperforming, and why might its laggard performance continue for longer than investors expect? Three reasons.

Exxon Mobil Corporation (NYSE:XOM

Exxon costs too much
When you stack up Exxon Mobil Corporation (NYSE:XOM) stock against its somewhat smaller rivals, it’s immediately clear that Exxon shares cost more than its peers. Valued on forward earnings, Exxon shares sell for a 15% premium to Chevron Corporation (NYSE:CVX)’s, and cost a whopping 51% more than BP plc (ADR) (NYSE:BP).

The overvaluation is apparent, too, when valuing the shares on trailing earnings, where Exxon’s 9.2 P/E ratio tops Chevron’s 8.9 and sells for a 53% premium to the 6 P/E at BP plc (ADR) (NYSE:BP).

Exxon grows too slow …
Now, this higher P/E ratio might be forgivable if Exxon Mobil Corporation (NYSE:XOM) was an obviously superior stock, with obviously brighter prospects than its peers. It’s not. Indeed, as this next chart shows, Exxon’s projected earnings growth rate over the next five years isn’t very much better than what’s expected out of Chevron Corporation (NYSE:CVX) — and lags BP plc (ADR) (NYSE:BP)’s projected pace quite badly.

… and it’s been growing slow for quite some time
Can we trust these analyst estimates to be accurate? Maybe not entirely. Crystal balls being both expensive, and notoriously hard to read, it’s certainly possible the analysts’ projected growth rates for BP plc (ADR) (NYSE:BP), Chevron Corporation (NYSE:CVX), and Exxon might be off by a point or two.

That said, it’s worth pointing out that the projections for the next five years’ earnings do line up pretty well with what we’ve already seen in these companies’ sales trends over the past five years.

So if past is prelude, it’s not all that hard to believe that the biggest oil company in the world might struggle to get even bigger, faster than its peers.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!